ASCENDing the anaplastic lymphoma kinase ladder: a tale of two C-nibs

Prabhat Singh Malik; Navneet Singh

首页> 外文期刊>Journal of Thoracic Disease >ASCENDing the anaplastic lymphoma kinase ladder: a tale of two C-nibs

【24h】

ASCENDing the anaplastic lymphoma kinase ladder: a tale of two C-nibs

机译：提升间变性淋巴瘤激酶阶梯：两个C-笔尖的故事

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Thoracic Disease》 |2016年第11期|共页
作者
Prabhat Singh Malik; Navneet Singh;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Phase II study of ceritinib in alectinib‐pretreated patients with anaplastic lymphoma kinase‐rearranged metastatic non‐small‐cell lung cancer in Japan: ASCEND‐9 [J] . Toyoaki Hida, Takashi Seto, Hidehito Horinouchi, Cancer science. . 2018,第9期

机译：ceritinib II期研究在日本接受alectinib治疗的间变性淋巴瘤激酶重新排列的转移性非小细胞肺癌患者：ASCEND-9
2. P1.01-012 Ceritinib in Anaplastic Lymphoma Kinase (ALK)+ NSCLC Patients Pretreated With Only Crizotinib: ASCEND-1 Subgroup Analysis [J] . A. Shaw, D. Kim, B. Solomon, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：P1.01-012 Ceritinib在促进淋巴瘤激酶（ALK）+ NSCLC患者仅用克里替尼预处理：Ascend-1亚组分析
3. ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non–Small Cell Lung [J] . Cho, B.C., D.-W., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第9期

机译：Ascend-8：随机阶段1研究Ceritinib，450mg或600mg，以低脂肪的膳食为750毫克，在患有间断淋巴瘤激酶（ALK） - 插入转移性非小细胞肺的患者中
4. Functional characterization of ubiquitination profile changes induced by oncogenic protein NPM-ALK in ALK~(+) anaplastic large cell lymphoma cells [C] . Fang Wu, Peng Wang, Raymond Lai, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

机译：致癌蛋白NPM-ALK诱导ubiquitination曲线变化的功能表征Ala1（+）促进大细胞淋巴瘤细胞
5. Understanding the function of the JunB transcription factor in anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma. [D] . Pearson, Joel Dylan. 2013

机译：了解JunB转录因子在间变性淋巴瘤激酶阳性，间变性大细胞淋巴瘤中的功能。
6. ASCENDing the anaplastic lymphoma kinase ladder: a tale of two C-nibs [O] . Prabhat Singh Malik, Navneet Singh 2016

机译：提升间变性淋巴瘤激酶阶梯：两个C-笔尖的故事
7. Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option [O] . Biagio Ricciuti, Giuseppe Lamberti, Fausto Roila, 2019

机译：Brigatinib用于促进淋巴瘤激酶 - 酪氨酸激酶抑制剂NaïveAnploplastic淋巴瘤激酶阳性晚期非小细胞肺癌：有效但仍然破裂的选择

ASCENDing the anaplastic lymphoma kinase ladder: a tale of two C-nibs

著录项

相似文献

相关主题

期刊订阅